Herceptin treats breast cancer effectively

According to a recent study by the Roche Gynecological Institute of the Red Cross based in Munich, Germany, patients of positive HER2 breast cancer can be optimistic thanks to herceptin antibiotics.

The use of herceptin (trastazumab) antibiotic in pre-surgery chemotherapy for breast cancer patients has yielded better results. This combination allows the complete removal of tumors of patients with HER2-positive cancer, three times higher than previous treatments.

Using trastazumab in pre-surgery chemotherapy for patients used by researchers in treatments called Neo-adjuvant.

Every year in the world, the number of people who die from breast cancer surpasses 400,000. In developed countries, thanks to advances in treatment, the proportion of patients cured is 85%.

The discovery of trastazumab in the treatment of this disease is a significant contribution that has changed the thinking in the treatment of cancer especially breast cancer.

Herceptin antibiotics (Photo: wdr.de)

Evening Primrose